Nkarta (NKTX) Revenue & Revenue Breakdown
Nkarta Revenue Highlights
00
Nkarta Revenue by Period
Nkarta Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | -100.00% |
| 2019-12-31 | $115.39K | -98.24% |
| 2018-12-31 | $6.55M | - |
Nkarta generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Nkarta Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $9.03M | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $10.54M | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | -100.00% |
| 2019-12-31 | $385.00 | -200.00% |
| 2019-09-30 | $-385.00 | -116.68% |
| 2019-06-30 | $2.31K | -97.96% |
| 2019-03-31 | $113.08K | - |
Nkarta generated - in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Nkarta Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| IPHA | Innate Pharma | $51.90M | $16.56M |
| FATE | Fate Therapeutics | $13.63M | $1.91M |
| TNXP | Tonix Pharmaceuticals | $10.09M | $2.43M |
| APLT | Applied Therapeutics | $455.00K | - |
| ACTU | Actuate Therapeutics | - | - |
| MCRB | Seres Therapeutics | - | - |
| ELTX | Elicio Therapeutics | - | - |
| NKTX | Nkarta | - | - |
| PEPG | PepGen | - | - |
| MIST | Milestone Pharmaceuticals | - | - |
| ACHV | Achieve Life Sciences | - | - |